There are 2137 resources available
1928O - Meta-analysis of tumour and T cell intrinsic mechanisms of sensitization to checkpoint inhibition
Presenter: Kevin Litchfield
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
1929O - Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients
Presenter: Giulia Mazzaschi
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
1930O - Genomic alterations in solid tumours according to ESMO scale for clinical actionability of molecular targets (ESCAT)
Presenter: Patricia Martin Romano
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
82O - Genomic evolution of metastatic tumours under therapeutic pressure
Presenter: Joris Van De Haar
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
1189O - Validation of whole genome sequencing in routine clinical practice
Presenter: Kim Monkhorst
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
LBA69 - Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients
Presenter: Florence Joly
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Abstract
Slides
Webcast
LBA71 - Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
Presenter: Trisha Wise-draper
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Abstract
Slides
Webcast
CN27 - Value of nurse navigators (NNs) telemonitoring for cancer patients (pts) tested positive for COVID-19
Presenter: Delphine Mathivon
Session: EONS13: Evolving roles in cancer nursing
Resources:
Abstract
Slides
Webcast
CN11 - How do patients value the role of the breast care nurse in the Catalan Institute of Oncology?
Presenter: Ana Rodriguez-ortega
Session: EONS13: Evolving roles in cancer nursing
Resources:
Abstract
Slides
Webcast
LBA15 - Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
Presenter: David Miles
Session: Proffered Paper - Breast cancer, metastatic 1
Resources:
Abstract
Slides
Webcast